Tyler Shultz became a whistleblower exposing Theranos, which was founded by Elizabeth Holmes in 2003. Holmes claimed Theranos could revolut...

Mochi Health has reduced their prices for their GLP-1 weight loss medications. While the membership fees is entirely separate, they have me...

Zydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...

A British Indian businessman and his ex-wife are fighting extradition to the US over allegations that they defrauded Medicare and other hea...

For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...

Inflated bills, delayed approvals, arbitrary deductions. As hospitals and insurers trade charges, policyholders are left footing the bill. ...

Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these f...

In a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...

The FDA is preparing to unveil new measures to accelerate approvals for vaping products and nicotine pouches. Changes will likely include r...

Presley Gerber, the son of renowned model Cindy Crawford, tragically passed away in a California rehabilitation facility on September 20, 2...

(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...

Maharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...

India's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...

On September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...

AstraZeneca's breast cancer drug Etcamah did not meet its main goal in a late-stage trial. The drug showed only a numerical improvement whe...

Indian equity markets experienced volatility, with the Nifty 50 extending its losing streak for four weeks. Escalating US-Iran hostilities ...